Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03411070 | SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer | completed | Early Phase 1 | 27 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT02826382 | Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041 | completed | Early Phase 1 | 14 | Five Eleven Pharma, Inc.INDUSTRY | 1 | Jan 12, 2023 | clinicaltrials |
| NCT03281811 | Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides | completed | Early Phase 1 | 11 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT03407716 | Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT02013492 | Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery | completed | Early Phase 1 | 1 | William CarsonOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT04114370 | Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma(FACBC) | completed | Early Phase 1 | 9 | James MountzOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT02851056 | Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT) | completed | Early Phase 1 | 14 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT02405078 | Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | completed | Early Phase 1 | 35 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT04797728 | Elacestrant in Preoperative Setting, a Window of Opportunity Study(ELIPSE) | completed | Early Phase 1 | 23 | SOLTI Breast Cancer Research GroupOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT04130152 | Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy(PROMETEO II) | completed | Early Phase 1 | 22 | SOLTI Breast Cancer Research GroupOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT02065609 | 89ZrTrastuzumab Breast Imaging With Positron Emission Tomography | completed | Early Phase 1 | 52 | Washington University School of MedicineOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT02072356 | Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery | completed | Early Phase 1 | 290 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT03858491 | Pharmacokinetic Boosting of Osimertinib(OSIBOOST) | completed | Early Phase 1 | 11 | Academisch Ziekenhuis MaastrichtOTHER | 1 | Sep 26, 2022 | clinicaltrials |
| NCT04267900 | 99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast Cancer | completed | Early Phase 1 | 34 | Peking Union Medical College HospitalOTHER | 1 | Sep 14, 2022 | clinicaltrials |
| NCT00962845 | Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | completed | Early Phase 1 | 20 | Rutgers, The State University of New JerseyOTHER | 1 | Sep 7, 2022 | clinicaltrials |
| NCT03020017 | NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery | completed | Early Phase 1 | 8 | Northwestern UniversityOTHER | 1 | Aug 26, 2022 | clinicaltrials |
| NCT03655756 | pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma | completed | Early Phase 1 | 7 | TuHURA Biosciences, Inc.INDUSTRY | 1 | Aug 8, 2022 | clinicaltrials |
| NCT04019834 | Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy(RELIEF) | completed | Early Phase 1 | 21 | University of Alabama at BirminghamOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT04065555 | Intratumoral Microdosing of TAK-981 in Head and Neck Cancer | completed | Early Phase 1 | 12 | Presage BiosciencesINDUSTRY | 1 | Jul 29, 2022 | clinicaltrials |
| NCT01781741 | Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer | completed | Early Phase 1 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT02885272 | FDG PET Imaging in Diagnosing Patients With Glioblastoma | completed | Early Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 21, 2022 | clinicaltrials |
| NCT03982407 | 68 Ga PSMA PET/MRI for Hepatocellular Carcinoma | completed | Early Phase 1 | 5 | Ajit H. Goenka, MDOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT02626130 | Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer | completed | Early Phase 1 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 7, 2022 | clinicaltrials |
| NCT02046694 | A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL | completed | Early Phase 1 | 34 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT04936997 | Immune Response to the COVID-19 Vaccine | completed | Early Phase 1 | 20 | University of ArizonaOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT04266392 | Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand | completed | Early Phase 1 | 20 | Stony Brook UniversityOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT05361083 | First-in-human Evaluation of [18F]CETO | completed | Early Phase 1 | 20 | Uppsala UniversityOTHER | 1 | May 4, 2022 | clinicaltrials |
| NCT03891654 | Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients | completed | Early Phase 1 | 3 | University of Colorado, DenverOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT03825718 | A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL | completed | Early Phase 1 | 29 | Hebei Yanda Ludaopei HospitalOTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT03028519 | Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer | completed | Early Phase 1 | 81 | University of OklahomaOTHER | 1 | Apr 19, 2022 | clinicaltrials |
| NCT03071328 | INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers | completed | Early Phase 1 | 10 | Duke UniversityOTHER | 1 | Apr 11, 2022 | clinicaltrials |
| NCT04142892 | Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer(ONAWA) | completed | Early Phase 1 | 10 | SOLTI Breast Cancer Research GroupOTHER | 1 | Apr 1, 2022 | clinicaltrials |
| NCT01979003 | Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion | completed | Early Phase 1 | 100 | University of ArkansasOTHER | 1 | Feb 24, 2022 | clinicaltrials |
| NCT02316834 | Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer(POSITION) | completed | Early Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 24, 2022 | clinicaltrials |
| NCT02855697 | Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer(MOLTO) | completed | Early Phase 1 | 28 | The Christie NHS Foundation TrustOTHER | 1 | Feb 22, 2022 | clinicaltrials |
| NCT04804163 | Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery | completed | Early Phase 1 | 47 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT03647657 | 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer | completed | Early Phase 1 | 8 | University Hospital, Basel, SwitzerlandOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| NCT03430934 | Non-invasive Fluorescent Imaging System for Imaging Mohs Tumor | completed | Early Phase 1 | 11 | University of Missouri-ColumbiaOTHER | 1 | Dec 9, 2021 | clinicaltrials |
| NCT03291990 | 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme | completed | Early Phase 1 | 3 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Nov 19, 2021 | clinicaltrials |
| NCT03018249 | Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer | completed | Early Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Nov 16, 2021 | clinicaltrials |
| NCT04882111 | ALIGN Intervention in Patients With Advanced Cancer Discharging to a SNF(ALIGN) | completed | Early Phase 1 | 45 | University of Colorado, DenverOTHER | 1 | Nov 11, 2021 | clinicaltrials |
| NCT01843634 | Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia | completed | Early Phase 1 | 10 | Jazz PharmaceuticalsINDUSTRY | 1 | Nov 10, 2021 | clinicaltrials |
| NCT04279535 | Topical Vitamin C for Treatment of Basal Cell Cancer | completed | Early Phase 1 | 25 | Center for Biomedical Research, Inc.INDUSTRY | 1 | Nov 2, 2021 | clinicaltrials |
| NCT01738815 | Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer | completed | Early Phase 1 | 43 | State University of New York - Upstate Medical UniversityOTHER | 1 | Oct 22, 2021 | clinicaltrials |
| NCT03158883 | UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients | completed | Early Phase 1 | 8 | Megan Daly, MDOTHER | 1 | Oct 20, 2021 | clinicaltrials |
| NCT04264962 | Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in Diameter(YYFZJDTRHCLT3D) | completed | Early Phase 1 | 300 | Beijing Ditan HospitalOTHER | 1 | Oct 12, 2021 | clinicaltrials |
| NCT03297489 | Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer | completed | Early Phase 1 | 19 | Roswell Park Cancer InstituteOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT01434342 | Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients | completed | Early Phase 1 | 146 | Wake Forest University Health SciencesOTHER | 1 | Sep 28, 2021 | clinicaltrials |
| NCT03972228 | Microdevice for Evaluating Drug Response in Site in Lung Lesions | completed | Early Phase 1 | 5 | Oliver JonasOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT00424242 | Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases | completed | Early Phase 1 | 15 | Northwestern UniversityOTHER | 1 | Sep 8, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Jan 17, 2023source: clinicaltrials